William Maughan
Stock Analyst at Clear Street
(4.30)
# 1,266
Out of 4,417 analysts
140
Total ratings
43%
Success rate
14.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintained: Buy | $338 → $311 | $341.66 | -8.97% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $32 → $31 | $14.07 | +120.33% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $39 → $36 | $5.95 | +505.04% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Maintained: Buy | $17 | $4.94 | +244.13% | 2 | Mar 30, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $37 | $32.48 | +13.92% | 5 | Mar 25, 2026 | |
| CLLS Cellectis | Maintained: Buy | $9 | $3.08 | +192.21% | 2 | Mar 20, 2026 | |
| KRRO Korro Bio | Maintained: Buy | $18 | $11.05 | +62.90% | 5 | Mar 13, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | $6.6 | $2.25 | +193.33% | 10 | Mar 13, 2026 | |
| MOLN Molecular Partners AG | Maintained: Buy | $8 | $3.86 | +107.25% | 4 | Mar 13, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $181 → $167 | $92.22 | +81.09% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.6 | $2.55 | +80.39% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $130 | $81.89 | +58.75% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $7.90 | +469.62% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $1.64 | +692.68% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $28 | $9.64 | +190.46% | 6 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $11.93 | +126.32% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $50 | $53.09 | -5.82% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $67 | $28.55 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $9.44 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $9 | $1.96 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $12.78 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $2.64 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $106 | $61.80 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $4.03 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $30.79 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $198.67 | n/a | 1 | Sep 5, 2022 |
Krystal Biotech
May 4, 2026
Maintained: Buy
Price Target: $338 → $311
Current: $341.66
Upside: -8.97%
Summit Therapeutics
May 1, 2026
Maintained: Buy
Price Target: $32 → $31
Current: $14.07
Upside: +120.33%
Wave Life Sciences
Apr 28, 2026
Maintained: Buy
Price Target: $39 → $36
Current: $5.95
Upside: +505.04%
Annexon
Mar 30, 2026
Maintained: Buy
Price Target: $17
Current: $4.94
Upside: +244.13%
Beam Therapeutics
Mar 25, 2026
Maintained: Buy
Price Target: $37
Current: $32.48
Upside: +13.92%
Cellectis
Mar 20, 2026
Maintained: Buy
Price Target: $9
Current: $3.08
Upside: +192.21%
Korro Bio
Mar 13, 2026
Maintained: Buy
Price Target: $18
Current: $11.05
Upside: +62.90%
Century Therapeutics
Mar 13, 2026
Maintained: Buy
Price Target: $6.6
Current: $2.25
Upside: +193.33%
Molecular Partners AG
Mar 13, 2026
Maintained: Buy
Price Target: $8
Current: $3.86
Upside: +107.25%
BioNTech SE
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $92.22
Upside: +81.09%
Mar 10, 2026
Maintained: Buy
Price Target: $4.6
Current: $2.55
Upside: +80.39%
Mar 10, 2026
Reiterated: Buy
Price Target: $100 → $130
Current: $81.89
Upside: +58.75%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $7.90
Upside: +469.62%
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $1.64
Upside: +692.68%
Mar 2, 2026
Maintained: Buy
Price Target: $21 → $28
Current: $9.64
Upside: +190.46%
Feb 26, 2026
Maintained: Buy
Price Target: $29 → $27
Current: $11.93
Upside: +126.32%
Nov 11, 2025
Maintained: Hold
Price Target: $45 → $50
Current: $53.09
Upside: -5.82%
May 23, 2024
Maintained: Hold
Price Target: $67
Current: $28.55
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $24
Current: $9.44
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $11 → $9
Current: $1.96
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $38
Current: $12.78
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $16 → $15
Current: $2.64
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $91 → $106
Current: $61.80
Upside: n/a
Feb 20, 2024
Maintained: Buy
Price Target: $60
Current: $4.03
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $30.79
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $198.67
Upside: n/a